CCL22 and hepatocellular carcinoma: demonstrated that miR-34a-5p expression is reduced in HBV-positive HCC, and its suppression facilitates tumor growth and metastasis by enhancing the expression of C-C motif chemokine ligand 22 (CCL22) 22.